Vycor Medical, Inc. (OTC: VYCO) operates in two segments to design, develop and market neurological medical devices and therapies in the United States and Europe. The company’s Vycor Medical segment provides brain and cervical surgical access systems to hospitals and medical professionals. The NovaVision segment offers neuro-stimulation therapies and diagnostic devices for the treatment and screening of vision field loss resulting from neurological damage. For more information, visit the company’s website at www.vycormedical.com